Catégorie : Uncategorized

septembre 11, 2019 0

ResMed annonce sa participation à la 17ème conférence annuelle de Morgan Stanley Global Healthca

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New…

septembre 10, 2019 0

ResMed annonce sa participation à la 17ème conférence annuelle de Morgan Stanley Global Healthca

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New…

septembre 8, 2019 0

ResMed annonce sa participation à la 17ème conférence annuelle de Morgan Stanley Global Healthca

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New…

septembre 6, 2019 0

ResMed annonce sa participation à la 17ème conférence annuelle de Morgan Stanley Global Healthca

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New…

septembre 4, 2019 0

ResMed annonce sa participation à la 17ème conférence annuelle de Morgan Stanley Global Healthca

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New…

septembre 3, 2019 0

ResMed annonce sa participation à la 17ème conférence annuelle de Morgan Stanley Global Healthca

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New…

juillet 2, 2019 0

Imbrium Therapeutics fait progresser le pipeline de l'insomnie en lançant une étude de phase 2 sur une molécule potentielle de première classe dans l'insomnie associée à la cessation de l'alcool

Par admin

STAMFORD, Connecticut – ( BUSINESS WIRE ) – Imbrium Therapeutics LP, une société biopharmaceutique au stade clinique et une filiale en exploitation de Purdue Pharma LP, a annoncé aujourd’hui le lancement de sa nouvelle molécule, IMB-115, potentiellement la première de sa catégorie précédemment dénommé IT-1315) à une étude clinique de phase 2 suivant les résultats…